04 junho 2020
03 junho 2020
Governments and WHO changed Covid-19 policy based on suspect data from tiny US company: Surgisphere, whose employees appear to include a sci-fi writer and adult content model, provided database behind Lancet and New England Journal of Medicine hydroxychloroquine studies
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis - The Lancet
A mysterious company’s coronavirus papers in top medical journals may be unraveling
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere | Concerns Build Over Surgisphere's COVID-19 Dataset
Response to Widespread Reaction to Recent Lancet Article on Hydroxychloroquine — Surgisphere Corporation
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis - The Lancet
A mysterious company’s coronavirus papers in top medical journals may be unraveling
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere | Concerns Build Over Surgisphere's COVID-19 Dataset
Response to Widespread Reaction to Recent Lancet Article on Hydroxychloroquine — Surgisphere Corporation
02 junho 2020
China delayed releasing coronavirus info, frustrating WHO: Chinese government labs only released the genome after another lab published it ahead of authorities on a virologist website on Jan. 11. Even then, China stalled for at least two weeks more on providing WHO with detailed data on patients and cases, according to recordings of internal meetings held by the U.N. health agency through January — all at a time when the outbreak arguably might have been dramatically slowed.
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis: Transmission of viruses was lower with physical distancing of 1 m or more, compared with a distance of less than 1 m
Subscrever:
Comentários (Atom)
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
The Oxford/AstraZeneca Vaccine Efficacy Data : We’re going to have to wait and collect more data to be able to say anything about these, fo...